Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Oct 23;18(1):20220750.
doi: 10.1515/biol-2022-0750. eCollection 2023.

Report on a case of liver-originating malignant melanoma of unknown primary

Affiliations
Case Reports

Report on a case of liver-originating malignant melanoma of unknown primary

Zheng Yuan et al. Open Life Sci. .

Abstract

Malignant melanoma (MM) frequently occurs in the skin or mucosa, whereas malignant melanoma of unknown primary (MUP) is diagnosed in patients with lymph nodes or visceral organs as the site of origin, where it is challenging to detect the primary lesion by comprehensive examination. MUP is possibly related to the spontaneous regression of the primary lesion. In addition, primary hepatic melanoma (PHM) usually refers to the primary MM occurring in the liver, with no typical primary lesions and no manifestations of tumor metastasis. A 61-year-old male patient with liver as the site of origin was diagnosed with MM by Melan-A, HMB-45, and S-100 immunohistochemistry staining of liver biopsy tissue. Based on a comprehensive examination, no basis was found for melanoma in sites such as the skin, mucosa, five sense organs, brain, digestive tract, respiratory tract, or genitalia, and the patient was subsequently diagnosed with MUP. MMs require a comprehensive inspection, beginning with the liver, to search for the primary lesion; if the primary lesion is not found, the possibility of PHM or MUP should be considered.

Keywords: diagnosis; liver; malignant melanoma; unknown primary.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Authors state no conflict of interest.

Figures

Figure 1
Figure 1
MRI shows diffuse space-occupying lesions of the liver, T1WI high signal (a), T2WI low signal (b), DWI high signal (c), and unequal enhancement of foci in the arterial phase (d).
Figure 2
Figure 2
PET-CT shows an increase in the SUV uptake value in multiple parts of the body (a), such as the liver and spleen (d), sternum and vertebrae (b), and other parts of the bone (c).
Figure 3
Figure 3
Liver histopathology (HE ×100) reveals nestlike cellular infiltration, accompanied by more pigmentation and nuclear enlargement with evident heteromorphism (a); the histopathology of pigmented nevi posterior to the left scapula (HE ×100) indicates benign cutaneous nevus (b).

References

    1. Jarti M, Boulajaad S, Gouton MU, Errami AA, Samlani Z, Oubaha S, et al. Primary liver melanoma: about a case. Pan Afr Med J. 2021;40:24. 10.11604/pamj.2021.40.24.29557. - DOI - PMC - PubMed
    1. Skarbez K, Fanciullo L. Metastatic melanoma from unknown primary presenting as dorsal midbrain syndrome. Optom Vis Sci. 2012;89(12):e112–7. - PubMed
    1. Kamposioras K, Pentheroudakis G, Pectasides D, Pavlidis N. Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature. Crit Rev Oncol Hematol. 2011;78(2):112–26. - PubMed
    1. Bae JM, Choi YY, Kim DS, Lee JH, Jang HS, Lee JH, et al. Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta- analysis of observational studies. J Am Acad Dermatol. 2015;72(1):59–70. - PubMed
    1. Pack GT, Gerber DM, Scharnagel IM. End results in the treatment of malignant melanoma; a report of 1190 cases. Ann Surg. 1952;136(6):905–11. - PMC - PubMed

Publication types

LinkOut - more resources